Stay updated on Gantenerumab in Mild Alzheimer Disease Clinical Trial

Sign up to get notified when there's something new on the Gantenerumab in Mild Alzheimer Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gantenerumab in Mild Alzheimer Disease Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.2 to v3.6.3 to reflect a newer site version.
    Difference
    0.0%
    Check dated 2026-07-06T16:30:07.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Added a new 2024 publication citation for Long-Term Safety of Gantenerumab in Alzheimer’s disease to the study's Publications list, listing authors Neve A et al. with the DOI; the revision tag was updated to v3.6.2.
    Difference
    0.0%
    Check dated 2026-06-29T08:58:54.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Recruitment status has been updated to closed, and new user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The removal of the old 'Intervention / Treatment' heading and the update to the site revision banner (v3.6.0) reflect a reorganization and version update.
    Difference
    0.2%
    Check dated 2026-06-14T18:17:30.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.5.4 to v3.5.5, indicating a newer page build. This reflects an update to the page’s versioning rather than changes to the study content.
    Difference
    0.0%
    Check dated 2026-06-07T15:42:30.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4, indicating a minor update to the site; the study details and navigation remain unchanged.
    Difference
    0.0%
    Check dated 2026-05-17T05:26:48.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The Malmö, Sweden entry replaces Malmo, Sweden, 211 46 to reflect the proper Swedish spelling in the study locations.
    Difference
    0.0%
    Check dated 2026-05-02T22:56:42.000Z thumbnail image

Stay in the know with updates to Gantenerumab in Mild Alzheimer Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gantenerumab in Mild Alzheimer Disease Clinical Trial page.